Strategic

Partners

Working together to promote innovation, accelerate evidence generation, and strengthen global clinical development.

Why Partnerships Matter

Complex medical innovation requires more than operational execution. Meditrial partners with academic institutions, international experts, and specialized organizations to support the next generation of clinical research, regulatory pathways, investigator education, simulation-based training, and global market expansion.

ISO Standards Development

Leadership in Regulatory Science Driving Medtech Global Compliance

Meditrial contributes to the development and advancement of international standards supporting quality, innovation, and clinical research excellence across the medical technology sector.

  • ISO 14155 – Clinical trials
  • ISO 5840 – Cardiac valve replacement
  • ISO 5910 – Cardiac valve repair
  • ISO 22679 – Cardiac occluders
  • ISO 18969 – Clinical evaluation of medical devices

Cornell University

Education & Clinical Research Training

Meditrial collaborates with Cornell University on educational initiatives and advanced training programs focused on clinical research, innovation, and healthcare leadership.

HEU EFS

Bocconi University

HEU-EFS Program & Early Feasibility Research

Meditrial collaborates with Bocconi University on initiatives related to early feasibility studies (EFS), innovation pathways, and emerging European frameworks supporting breakthrough medical technologies.

SDA Bocconi

School of Management

Partnership supporting thought leadership, executive education, research initiatives, and multidisciplinary collaboration to accelerate innovation and strengthen the future of global healthcare and clinical development.

Simulands

Simulation-Based Clinical Training

Meditrial partners with Simulands to strengthen procedural excellence through advanced simulation-based physician training programs supporting both clinical trials and commercial readiness.

Meditrial-Binur

China Market Program

China Market Access & Strategic Expansion

Through its collaboration with ARSUF Global Partners and Yuval Binur, Meditrial supports companies exploring strategic entry into the Chinese healthcare and MedTech ecosystem, including regulatory, commercial, and partnership considerations.

Building an Ecosystem for the Future of Clinical Research

Meditrial’s partnerships are built around a shared objective: accelerating innovation while strengthening the quality, credibility, education, and global scalability of clinical evidence generation.

Together with academic institutions, international experts, technology innovators, and standards organizations, we help shape the future of modern clinical development.

  • Innovation
  • Evidence

  • Education

  • Quality

  • Global Impact

Stronger together.

Our partnerships are built on trust, shared purpose, and a commitment to improving patient outcomes worldwide.